Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders
A 435-word research paper, formatted in APA 7 (about 2 double-spaced pages).
- Type
- Research Paper
- Length
- 435 words, 2 pages
- Style
- APA 7
Research PaperAPA 7
Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders
Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders
Once the underlying cause is identified, an appropriate drug therapy plan can be recommended based on medical history and individual patient factors. In this Assignment, you examine a case study of a patient who presents with symptoms of a possible GI/hepatobiliary disorder, and you design an appropriate drug therapy plan.
To Prepare
- Review the case study assigned by your Instructor for this Assignment
- Reflect on the patient’s symptoms, medical history, and drugs currently prescribed.
- Think about a possible diagnosis for the patient. Consider whether the patient has a disorder related to the gastrointestinal and hepatobiliary system or whether the symptoms are the result of a disorder from another system or other factors, such as pregnancy, drugs, or a psychological disorder.
- Consider an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
By Day 7 of Week 4
Write a 1-page paper that addresses the following:
- Explain your diagnosis for the patient, including your rationale for the diagnosis.
- Describe an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
- Justify why you would recommend this drug therapy plan for this patient. Be specific and provide examples.
Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http://writingcenter.waldenu.edu/57.htm). All papers submitted must use this formatting.
Submission and Grading Information
To submit your completed Assignment for review and grading, do the following:
- Please save your Assignment using the naming convention “WK4Assgn+last name+first initial.(extension)†as the name.
- Click the Week 4 Assignment Rubric to review the Grading Criteria for the Assignment.
- Click the Week 4 Assignment link. You will also be able to “View Rubric†for grading criteria from this area.
- Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK4Assgn+last name+first initial.(extension)†and click Open.
- If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.
- Click on the Submit button to complete your submission.
Grading Criteria
To access your rubric:
Week 4 Assignment Rubric
Check Your Assignment Draft for Authenticity
To check your Assignment draft for authenticity:
Submit your Week 4 Assignment draft and review the originality report.
Submit Your Assignment by Day 7 of Week 4
To participate in this Assignment:
Week 4 Assignment
What’s Coming Up in Module 4?
This paper is a sample from a completed student assignment, published to help you understand structure, argument and APA formatting. Use it for inspiration and reference only, and cite it if you quote it.
Get this paper as a Word file
pharmacotherapy-for-gastrointestinal-and-hepatob.docx, with an APA title page and reference list, ready to edit in Word or Google Docs.
Need a custom paper on Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders?
Get an original, plagiarism-free paper written to your rubric by a nursing expert.
Cite This Paper
Pick your style, then copy. Italics are kept when you paste into Word or Google Docs.
Premium Academic Affiliates. (2021, August 27). Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders [Research paper example]. https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/
(Premium Academic Affiliates, 2021)
Premium Academic Affiliates. (2021, August 27). Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders [Research paper example]. Retrieved from https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/
(Premium Academic Affiliates, 2021)
“Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders.” Premium Academic Affiliates, 27 Aug. 2021, premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders.
(“Pharmacotherapy for Gastrointestinal”)
Premium Academic Affiliates (2021) Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders. Available at: https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/ (Accessed: 15 October 2026).
(Premium Academic Affiliates, 2021)
Premium Academic Affiliates. 2021. “Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders.” August 27, 2021. https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/.
(Premium Academic Affiliates 2021)
Premium Academic Affiliates. “Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders.” August 27, 2021. https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/.
1. Premium Academic Affiliates, “Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders,” August 27, 2021, https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/.
Premium Academic Affiliates. Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders [Internet]. 2021 Aug 27 [cited 2026 Oct 15]. Available from: https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/
[1] or (1)
Premium Academic Affiliates. Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders. Published August 27, 2021. Accessed October 15, 2026. https://premiumacademicaffiliates.com/pharmacotherapy-for-gastrointestinal-and-hepatobiliary-disorders/
1
Published . Updated .







